Rajangam Kanya 4
4 · Senti Biosciences, Inc. · Filed Mar 11, 2025
Insider Transaction Report
Form 4
Rajangam Kanya
Pres. & Chief Med. & Dev. Off.
Transactions
- Conversion
Common Stock
2025-03-10$2.25/sh+33,000$74,250→ 33,000 total(indirect: By Trust) - Conversion
Series A Convertible Preferred Stock
2025-03-10$2250.00/sh−33$74,250→ 0 total(indirect: By Trust)Exercise: $2.25From: 2025-03-10→ Common Stock (33,000 underlying)
Holdings
- 86,984
Common Stock
Footnotes (2)
- [F1]The reporting person and her spouse are trustees of the Iyer Family Revocable Trust dated Aug 26 2012. Each of the reporting person and her spouse have voting and dispositive power over the Series A Preferred Stock, Common Stock and Warrants. The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F2]The shares of Series A Convertible Preferred Stock have no expiration date.